Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Acceliant to Participate in DIA India's 7th Annual Conference to be Held at Hyderabad
Acceliant, a global technology provider of innovative clinical solutions, will participate in DIA India's 7th Annual Conference, scheduled for Nov. 1-4, 2012 at the Hyderabad International Convention Center, Novotel & HICC Complex, Hyderabad. Acceliant invites all the conference attendees to... - October 27, 2012 - Trianz
Rosellini Scientific, LLC Announces Recent Hire of Dr. Austin Duke as Vice President of Emerging Technologies
Rosellini Scientific, LLC is pleased to announce the recent hire of Dr. Austin Duke to join their team as Vice President of Emerging Technologies. - October 26, 2012 - Rosellini Scientific, LLC
The Essentials for Understanding How to Put Spinal Cord Injury Research Into Clinical Practice
According to the National Spinal Cord Injury Statistical Center, there are approximately 12,000 new cases of spinal cord injury per year in the United States alone. There have been some extraordinary breakthroughs in spinal cord injury (SCI) research recently, and the challenge is to ensure that... - October 26, 2012 - Thieme Publishers
Lung Cancer Surgeon at South Nassau Communities Hospital Named Director of Clinical Research
A recipient of the ACS CoC Outstanding Performance Award, Dr. Shahriyour Andaz is board-certified in both thoracic and general surgery and specializes in complex chest cancer procedures and robotic-assisted surgery. - October 24, 2012 - Mount Sinai South Nassau
Amazing Spaces® Storage Center Area Residents Donate Funds to Support Shriners Hospital for Children in Galveston, Partner with Texas Self Storage Association
Leader in self storage, Amazing Spaces Storage Centers®, raises money from customers, associates, friends, and family members to benefit the Shriners Hospitals for Children, a world-class hospital system that saves and improves the lives of children regardless of their family's ability to pay. Houston local communities rose to the challenge to donate. - October 22, 2012 - Amazing Spaces Storage Centers
Chief Medical Officer at South Nassau Named Clinical Professor of Medicine at Hofstra NSLIJ School of Medicine
South Nassau and Hofstra NSLIJ School of Medicine have an academic affiliation agreement that combines the school’s academic and clinical resources with the hospital's clinical programs and physicians to provide world class medical training. - October 20, 2012 - Mount Sinai South Nassau
VersaSuite Receives CCHIT Clinical Research Certification
VersaSuite 8.0 is the first ever product to receive CCHIT’s add-on Clinical Research Certification. - October 16, 2012 - VersaSuite
New Jersey Law Firm Assists Victims During Fungal Meningitis Outbreak From Tainted Epidural Steroid Injections
New Jersey personal injury lawyer Scott Grossman is currently investigating the current Fungal Meningitis outbreak in New Jersey and in several other states and is making himself available to victims for consultation. The United States Centers for Disease Control and Prevention (CDC) announced that... - October 15, 2012 - The Grossman Law Firm, LLC
Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism
Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC
ALPCO’s Mouse Sclerostin ELISA to be Featured at ASBMR
A collaboration between ALPCO Diagnostics and the Mayo Clinic has yielded a poster that will be presented at this year’s ASBMR meeting in Minneapolis, MN. - October 04, 2012 - ALPCO
Hepatitis B Foundation Adds Dr. Ford-Hutchinson to Board of Directors
National Nonprofit Dedicated to Finding a Cure for Hepatitis B Welcomes Former Merck & Co. Executive Anthony W. Ford-Hutchinsonto Board. - September 28, 2012 - Hepatitis B Foundation
IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry. Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.
New DART-OS Source Demonstrated Live to Meeting Attendees, Highlighting Applications in Food Safety and Forensics. - September 27, 2012 - IonSense, Inc.
SimpleCTMS Expands to Europe with QED Clinical Services
Trial By Fire Solutions, a leading eClinical solution provider specializing in clinical study management applications, today announced that QED Clinical Services Limited, a specialty Contract Research Organization (CRO) based in the United Kingdom, has selected SimpleCTMS to broaden and enhance... - September 25, 2012 - Trial By Fire Solutions
Source-Omega Claims JAMA Meta-Study Unethical; Calls for Ban of the Word Omega-3 on Drug Labels
Source-Omega says the Food and Drug Administration may need to ban the use of the word omega-3 on all drug labels and descriptions. That is, if omega-3 is only a food word. This is at issue because the company says the September 12th JAMA study also misleads those benefiting from current... - September 20, 2012 - Source-Omega
New Phase 2 Paid Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research in Central Florida; Accepting Male & Female Participants Age 18-70
The primary objectives of this study are to evaluate the 12-week safety, antiviral activity and tolerability of this new Hep C drug when given in combination with PEG and RIBA as measured by extended rapid virologic response. - September 19, 2012 - Avail Clinical Research
New Phase 2 Rheumatoid Arthritis Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; 35 Locations Throughout the U.S.
The objective of this study is to evaluate the safety and efficacy of a new Rheumatoid Arthritis monotherapy in moderate to severe Rheumatoid Arthritis (RA) subjects. - September 18, 2012 - Achieve Clinical Research
Institute for Hepatitis and Virus Research Receives Significant State Grant for Two-Year Research Project Focusing on New Liver Cancer Treatment
Institute for Hepatitis and Virus Research Receives Significant State Grant for Two-Year Research Project Focusing on New Liver Cancer Treatment - September 16, 2012 - Hepatitis B Foundation
Achieve Clinical Research is Conducting New Rheumatoid Arthritis Trials in Birmingham, Alabama
Achieve Clinical Research, located in Birmingham, AL, has started enrolling participants for a new Rheumatoid Arthritis clinical trial. The study is open to adults ages 18 - 75 who have been diagnosed with Rheumatoid Arthritis. - September 14, 2012 - Achieve Clinical Research
pharmaCline Announces Poster Presentation at the Symposium for the Advancement of Wound Care Fall 2012
The poster entitled, “Multi-case Human Field Studies of Diabetic Foot Injuries Treated with Tetracycline delivered by SSPT™: A Novel Delivery System Yields Effective Results” is authored by Dr. Christopher Ayo Otiko, DPM, and features three unique clinical case studies. - September 13, 2012 - pharmaCline
KJT Group Expands with New European Office
KJT Group, Inc. is pleased to announce it has established its first European office, in the Netherlands. - September 07, 2012 - KJT Group
ALPCO Adds an FDA Registered ELISA for West Nile Virus
ALPCO announces the addition of two FDA Registered ELISAs for the measurement of West Nile Virus. - September 05, 2012 - ALPCO
The Light Study, a New Long-Term Weight Management Research Study, Begins Enrolling Patients at Wake Research Associates in Raleigh, NC
“Take Five to Live Light” Campaign Launched for Obesity Awareness Wake Research Associates today announced that the Light Study, a unique medical research study evaluating an investigational medication for weight loss, has begun enrolling patients at its site. The research study is... - August 31, 2012 - Wake Research Associates
VIRUN® Receives Eighth Notice-of-Allowance for Patent Applications and Introduces New “Space” Within Industry
After only a short while, VIRUN has obtained numerous Notice-of-Allowances and several patent grants for its nano-encapsulation technologies that allow non polar compounds, such as CoQ10 and Omega-3 EPA DHA, to dissolve clearer and shelf stable into foods and beverages. With this increase in patent proliferation, VIRUN introduces the NUTRA-BIOsciences™ platform to accelerate the expansion and exclusivity of new and added-value food/beverage products. - August 30, 2012 - VIRUN
KJT Group Appoints Chief Financial Officer and Chief of Staff
KJT Group names Michaela Gascon as Chief Financial Officer and Lynn Clement as Chief of Staff. Michaela Gascon has been appointed Chief Financial Officer for KJT Group and will oversee the financial analysis and reporting functions for the organization. Lynn Clement will assume the role of Chief... - August 30, 2012 - KJT Group
Drug Development Requires Flexibility in Clinical Trial Design: ICRC-Weyer Clinical CRO Interview
Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation. - August 22, 2012 - ICRC-Weyer GmbH
InClin Selects SimpleCTMS for Clinical Study Management Optimization
InClin, a San Francisco Bay Area Clinical Research Organization (CRO), has selected SimpleCTMS, a leading eClinical study management solution, as part of a growing initiative to enhance their clinical research service offering. As their operations continue to expand, it will be critical for InClin... - August 17, 2012 - Trial By Fire Solutions
DataServices, LLC Rebrands and Launches Lab Portal Company and Website
DataServices, LLC unveiled a new company name, Lab Portal Company. The Lab Portal Company Electronic Results Portal allows a laboratory or lab business entity to provide customizable test results to their customer network. - July 26, 2012 - Lab Portal Compancy
New Medical Coding Procedures at Clinical CRO ICRC-Weyer
The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has changed its coding procedures for medications, enabling the company to offer enhanced solutions to a broad client base. - July 20, 2012 - ICRC-Weyer GmbH
Rosellini Scientific, LLC Hires New Chief Medical Officer
Rosellini Scientific, LLC is pleased to announce the hiring of Barry Kraynack as Chief Medical Officer. Barry Kraynack is a board certified anesthesiologist who has more than 30 years as a preclinical and clinical researcher in translational medicine. Barry will be responsible for the identification of new technologies for commercialization, monetization or sales and distribution in the life science space, encompassing medical devices. - July 17, 2012 - Rosellini Scientific, LLC
National Foundation for Cancer Research Announces Partnership with Give by Cell for Mobile Fundraising
Give by Cell, a San Francisco based company specializing in mobile technology solutions, was selected by the National Foundation for Cancer Research (NFCR) to provide the organization with its mobile fundraising service, Mobile Give, allowing NFCR supporters to make donations via text. “Like... - July 11, 2012 - Give by Cell
Christopher & Dana Reeve Foundation Partners with Give by Cell for Mobile Fundraising
Give by Cell, a San Francisco based company specializing in mobile technology solutions, was selected by the Christopher & Dana Reeve Foundation to provide the mobile fundraising service, Mobile Give, allowing supporters to make donations via text. "The landscape of philanthropy is... - July 11, 2012 - Give by Cell
ALPCO Diagnostics Launches Mouse Sclerostin ELISA
ALPCO Diagnostics announces the launch of an ELISA specific for measuring mouse sclerostin in serum and plasma. - July 10, 2012 - ALPCO
Donate DNA and Help Further Tourette Syndrome Research on July 23-24, August 6-7 at Rutgers University
Yale University’s Dr. Robert King will interview families interested in participating in the genetics sharing program at the Cell and DNA Repository, which the New Jersey Center for Tourette Syndrom helped found in 2007. - July 09, 2012 - New Jersey Center for Tourette Syndrome
Favourable Regulatory Environment in India Drives Indian Stem Cell Research, Finds Netscribes
Netscribes, launches a report on the Stem Cell Research in India 2012 as part of Netscribes’ Healthcare Industry report series. - July 08, 2012 - Netscribes, Inc.
GoldBio Becomes Certified Philips LED Horti Partner
Philips announces that Gold Biotechnology, Inc., a supplier of molecular biology research chemicals based in St. Louis, MO, has become a certified Philips LED Horti Partner. Bart Saracino (Director of Marketing at GoldBio), Udo van Slooten (Director of Horticulture LED at Philips) and Erik Jansen... - July 07, 2012 - Gold Biotechnology, Inc
ALPCO & Argutus Medical Collaboration
Kidney & Liver Toxicity Gold Standard Rat Alpha GST ELISA Available Once Again - June 26, 2012 - ALPCO
ALPCO Diagnostics Recognized for Support of the American Red Cross 2011 Relief Efforts
ALPCO was recognized on May 29, 2012 for their generous contributions to the American Red Cross in 2011. - June 11, 2012 - ALPCO
California’s Stem Cell Agency’s New Strategic Plan Outlines Vision for the Future
Creative partnerships to move promising stem cell therapies into clinical trials; a pioneering new kind of clinic to help deliver those therapies to patients; and a renewed commitment to delivering health and economic benefits to California - those are some of the key elements in the new Strategic... - June 09, 2012 - California Institute for Regenerative Medicine
Source-Omega Gives Omega-3 Guidance in Times of Change
Source-Omega today announced their offerings for companies seeking security, freedom and a 5 year supply agreement in algae oil for price and quality improvements in times of change. "Why fear when I am here," Says Dr Scott Doughman, PhD, owner of Source-Omega, a supplier of DHA... - May 20, 2012 - Source-Omega
Michael Marletta Appointed to Governing Board of California’s Stem Cell Agency
Michael A. Marletta, PhD, President and CEO of The Scripps Research Institute, has been appointed to the Independent Citizens Oversight Committee (ICOC), the governing board of California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM). “California has led... - May 20, 2012 - California Institute for Regenerative Medicine
Ameridose Announces Silver Sponsorship of USP 797 Compliance Study
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is delighted to be a silver sponsor for the 2nd annual USP <797> Compliance Study. The 2012 study will run from May 1 – June 30, collecting survey data from facilities engaged in sterile... - May 18, 2012 - Ameridose, LLC
IonSense Presenting OpenSpot Mass Spectrometry™ at the American Society for Mass Spectrometry Annual Conference
OpenSpot™ Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Costs and Lab Waste. Exhibited at ASMS 2012. Booth #57. - May 17, 2012 - IonSense, Inc.
Low Body Temperature Plays a Key Role in Fibromyalgia and Chronic Illness
In the latest issue of Fibromyalgia Solutions, Dr. David Jernigan discusses the link between low body temperature and fibromyalgia. - May 16, 2012 - Hansa Center for Optimum Health
New Design Cuts Nurse-Injuries and Accelerates Patient Recovery
As hospital design progresses and makes patients recover faster, the alarm-bell keeps ringing for all the nurses getting injured. - May 12, 2012 - Integra care products
Nettfit Publishing Presents "Marijuana for Parkinson Disease," a New Controversial Cannabis Research Book in Print Now
Pharmaceutical use of cannabis is not new and history shows us how this miracle plant has been misinterpreted through an era of ignorance. Cannabis has been used for thousands of years and the credibility of marijuana as a therapy specifically for Parkinson’s disease is somewhat new. “Marijuana is a miracle plant that helps Parkinson’s patients and benefits people suffering from many other illnesses,” states PD patient and author of, "Marijuana for Parkinson's Disease" (2012). - May 10, 2012 - Nettfit Publishing
Fertility Preservation Network Collaborates with National Disease Research Interchange
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissues (sperm, eggs, embryos and ovarian and testicular tissue), announces its partnership with the National Disease Research Interchange in its efforts to provide tissue for research. - May 10, 2012 - ReproTech, LLC
ICRC-Weyer Enhance Medical Data Management Services
The German contract research organization, ICRC-Weyer GmbH, has recently increased its efforts to deliver high-quality, expert medical data management services to the clinical research community. With this step, the Berlin-based CRO further consolidates its leading position within the market of mid-sized clinical research services providers. - May 10, 2012 - ICRC-Weyer GmbH
Opti Sleep Releases Insomnia Trial Data
Opti Sleep, the new clinically proven treatment for sleep problems, has released details of its latest clinical study to treat insomnia and those suffering from interrupted sleep, showing improved sleep response in over 90% of participants. - April 30, 2012 - Opti Sleep
Hoag Participating in Clinical Trial for Aggressive Brain Cancer
Brain Cancer Vaccine for Local Brain Cancer Patients now available as a research option in Orange County. - April 26, 2012 - Hoag Memorial Hospital Presbyterian
Privacy Analytics Unveils Version 2.5 of Its Unique Integrated De-identification and Intelligent Data Masking Software
The developer of the only commercially available integrated de-identification and intelligent data masking solution for the secondary use of personal health information announces the release of PARAT 2.5 (Privacy Analytics Risk Assessment Tool). - April 23, 2012 - Privacy Analytics Inc.